{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:54:22Z","timestamp":1787072062761,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,18]]},"DOI":"10.7759\/cureus.114745","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:17:47Z","timestamp":1787069867000},"source":"Crossref","is-referenced-by-count":0,"title":["Levosimendan for Weaning From Veno-Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock: An Umbrella Review"],"prefix":"10.7759","author":[{"given":"Abhishek Hanumanpratap Singh","family":"Kshatri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minahil","family":"Saif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semil","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zauraiz","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azlaan","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd13010009","article-title":"Cardiogenic shock management in the modern era: a narrative review of percutaneous mechanical circulatory support devices","volume":"13","author":"Jana S","year":"2025","unstructured":"Jana S, Wijesinghe M, DiCaro MV, Lei K, Houshmand N, Ahsan C. Cardiogenic shock management in the modern era: a narrative review of percutaneous mechanical circulatory support devices. J Cardiovasc Dev Dis. 2025, 13:10009. 10.3390\/jcdd13010009","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2025.101732","article-title":"Mortality trends related to cardiogenic shock in heart failure patients aged 25 and older across the United States: a study utilizing the CDC WONDER database from 1999 to 2023","volume":"59","author":"Muhammad AN","year":"2025","unstructured":"Muhammad AN, Neppala S, Chigurupati HD, et al.. Mortality trends related to cardiogenic shock in heart failure patients aged 25 and older across the United States: a study utilizing the CDC WONDER database from 1999 to 2023. Int J Cardiol Heart Vasc. 2025, 59:101732. 10.1016\/j.ijcha.2025.101732","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3583","article-title":"Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shock","volume":"27","author":"Dettling A","year":"2025","unstructured":"Dettling A, Kellner C, Sundermeyer J, et al.. Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shock. Eur J Heart Fail. 2025, 27:832-41. 10.1002\/ejhf.3583","journal-title":"Eur J Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18105-y","article-title":"Predictors of weaning failure in case of VA ECMO implantation","volume":"12","author":"Cusanno A","year":"2022","unstructured":"Cusanno A, Aissaoui N, Minville V, et al.. Predictors of weaning failure in case of VA ECMO implantation. Sci Rep. 2022, 12:13842. 10.1038\/s41598-022-18105-y","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2021.01.019","article-title":"The effectiveness of levosimendan on veno-arterial extracorporeal membrane oxygenation management and outcome: a systematic review and meta-analysis","volume":"35","author":"Kaddoura R","year":"2021","unstructured":"Kaddoura R, Omar AS, Ibrahim MI, et al.. The effectiveness of levosimendan on veno-arterial extracorporeal membrane oxygenation management and outcome: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2021, 35:2483-95. 10.1053\/j.jvca.2021.01.019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-023-02208-1","article-title":"Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"113","author":"Liu Y","year":"2024","unstructured":"Liu Y, Zhang L, Yao Y, et al.. Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. Clin Res Cardiol. 2024, 113:509-21. 10.1007\/s00392-023-02208-1","journal-title":"Clin Res Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.741108","article-title":"Levosimendan to facilitate weaning from cardiorespiratory support in critically ill patients: a meta-analysis","volume":"8","author":"Luo JC","year":"2021","unstructured":"Luo JC, Zheng WH, Meng C, et al.. Levosimendan to facilitate weaning from cardiorespiratory support in critically ill patients: a meta-analysis. Front Med (Lausanne). 2021, 8:741108. 10.3389\/fmed.2021.741108","journal-title":"Front Med (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/02676591211051860","article-title":"Short-term effects of levosimendan use for venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"38","author":"Yang B","year":"2023","unstructured":"Yang B, Zhao T, Guo B, Li Y. Short-term effects of levosimendan use for venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. Perfusion. 2023, 38:305-12. 10.1177\/02676591211051860","journal-title":"Perfusion"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.19843","article-title":"Levosimendan to facilitate weaning from ECMO in patients with severe cardiogenic shock: the LEVOECMO randomized clinical trial","volume":"335","author":"Combes A","year":"2026","unstructured":"Combes A, Saura O, Nesseler N, et al.. Levosimendan to facilitate weaning from ECMO in patients with severe cardiogenic shock: the LEVOECMO randomized clinical trial. JAMA. 2026, 335:60-9. 10.1001\/jama.2025.19843","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070849","article-title":"Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement","volume":"378","author":"Gates M","year":"2022","unstructured":"Gates M, Gates A, Pieper D, et al.. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. 2022, 378:e070849. 10.1136\/bmj-2022-070849","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/publications14010004","article-title":"The Newcastle-Ottawa scale for assessing the quality of studies in systematic reviews","volume":"14","author":"Gualdi-Russo E","year":"2026","unstructured":"Gualdi-Russo E, Zaccagni L. The Newcastle-Ottawa scale for assessing the quality of studies in systematic reviews. Publications. 2026, 14:4. 10.3390\/publications14010004","journal-title":"Publications"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/0267659120918473","article-title":"Effects of levosimendan on weaning and survival in adult cardiogenic shock patients with veno-arterial extracorporeal membrane oxygenation: systematic review and meta-analysis","volume":"35","author":"Burgos LM","year":"2020","unstructured":"Burgos LM, Seoane L, Furmento JF, et al.. Effects of levosimendan on weaning and survival in adult cardiogenic shock patients with veno-arterial extracorporeal membrane oxygenation: systematic review and meta-analysis. Perfusion. 2020, 35:484-91. 10.1177\/0267659120918473","journal-title":"Perfusion"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-5683.22.06054-9","article-title":"Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis","volume":"71","author":"Bertini P","year":"2023","unstructured":"Bertini P, Paternoster G, Landoni G, et al.. Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis. Minerva Cardiol Angiol. 2023, 71:564-74. 10.23736\/S2724-5683.22.06054-9","journal-title":"Minerva Cardiol Angiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-101995","article-title":"Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis","volume":"15","author":"Zhao GM","year":"2025","unstructured":"Zhao GM, Zhao GM, Zhang H, Chen W, Zhou JX, Li HL. Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis. BMJ Open. 2025, 15:e101995. 10.1136\/bmjopen-2025-101995","journal-title":"BMJ Open"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-019-0503-1","article-title":"Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit","volume":"9","author":"Vally S","year":"2019","unstructured":"Vally S, Ferdynus C, Persichini R, et al.. Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit. Ann Intensive Care. 2019, 9:24. 10.1186\/s13613-019-0503-1","journal-title":"Ann Intensive Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0b013e3182a4b32e","article-title":"Levosimendan may improve weaning outcomes in venoarterial ECMO patients","volume":"59","author":"Affronti A","year":"2013","unstructured":"Affronti A, di Bella I, Carino D, Ragni T. Levosimendan may improve weaning outcomes in venoarterial ECMO patients. ASAIO J. 2013, 59:554-7. 10.1097\/MAT.0b013e3182a4b32e","journal-title":"ASAIO J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aew151","article-title":"Beneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery","volume":"117","author":"Distelmaier K","year":"2016","unstructured":"Distelmaier K, Roth C, Schrutka L, et al.. Beneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery. Br J Anaesth. 2016, 117:52-8. 10.1093\/bja\/aew151","journal-title":"Br J Anaesth"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2018.04.019","article-title":"Comparison of levosimendan and milrinone for ECLS weaning in patients after cardiac surgery: a retrospective before-and-after study","volume":"32","author":"Jacky A","year":"2018","unstructured":"Jacky A, Rudiger A, Kr\u00fcger B, et al.. Comparison of levosimendan and milrinone for ECLS weaning in patients after cardiac surgery: a retrospective before-and-after study. J Cardiothorac Vasc Anesth. 2018, 32:2112-9. 10.1053\/j.jvca.2018.04.019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216408","article-title":"Use of levosimendan in patients with advanced heart failure: an update","volume":"11","author":"Masarone D","year":"2022","unstructured":"Masarone D, Kittleson MM, Pollesello P, et al.. Use of levosimendan in patients with advanced heart failure: an update. J Clin Med. 2022, 11:6408. 10.3390\/jcm11216408","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/513572-levosimendan-for-weaning-from-veno-arterial-extracorporeal-membrane-oxygenation-in-cardiogenic-shock-an-umbrella-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:17:48Z","timestamp":1787069868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/513572-levosimendan-for-weaning-from-veno-arterial-extracorporeal-membrane-oxygenation-in-cardiogenic-shock-an-umbrella-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.114745","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}